Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.
Fettiplace A, Marcinak J, Merz M, Zhang HT, Kikuchi L, Regev A, Palmer M, Rockey D, Fontana R, Hayashi PH, Tillmann HL, Di Bisceglie AM, Lewis JH. Fettiplace A, et al. Among authors: rockey d. Aliment Pharmacol Ther. 2024 Nov;60(10):1293-1307. doi: 10.1111/apt.18271. Epub 2024 Sep 19. Aliment Pharmacol Ther. 2024. PMID: 39300766 Review.
Signatures in drug-induced liver injury.
Tillmann HL, Rockey DC. Tillmann HL, et al. Curr Opin Gastroenterol. 2020 May;36(3):199-205. doi: 10.1097/MOG.0000000000000636. Curr Opin Gastroenterol. 2020. PMID: 32205565 Free PMC article. Review.
Death and liver transplantation within 2 years of onset of drug-induced liver injury.
Hayashi PH, Rockey DC, Fontana RJ, Tillmann HL, Kaplowitz N, Barnhart HX, Gu J, Chalasani NP, Reddy KR, Sherker AH, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN) Investigators. Hayashi PH, et al. Hepatology. 2017 Oct;66(4):1275-1285. doi: 10.1002/hep.29283. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28543844 Free PMC article.
Tools for causality assessment in drug-induced liver disease.
Tillmann HL, Suzuki A, Barnhart HX, Serrano J, Rockey DC. Tillmann HL, et al. Curr Opin Gastroenterol. 2019 May;35(3):183-190. doi: 10.1097/MOG.0000000000000526. Curr Opin Gastroenterol. 2019. PMID: 30865042 Free PMC article. Review.
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.
Treem WR, Palmer M, Lonjon-Domanec I, Seekins D, Dimick-Santos L, Avigan MI, Marcinak JF, Dash A, Regev A, Maller E, Patwardhan M, Lewis JH, Rockey DC, Di Bisceglie AM, Freston JW, Andrade RJ, Chalasani N. Treem WR, et al. Among authors: rockey dc. Drug Saf. 2021 Feb;44(2):133-165. doi: 10.1007/s40264-020-01014-2. Epub 2020 Nov 3. Drug Saf. 2021. PMID: 33141341 Free PMC article. Review.
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.
Hey-Hadavi J, Seekins D, Palmer M, Coffey D, Caminis J, Abdullaev S, Patwardhan M, Tyler H, Raheja R, Stanley AM, Pineda-Salgado L, Bourdet DL, Andrade RJ, Hayashi PH, Dimick-Santos L, Rockey DC, Estilo A. Hey-Hadavi J, et al. Among authors: rockey dc. Drug Saf. 2021 Jun;44(6):619-634. doi: 10.1007/s40264-021-01051-5. Epub 2021 Mar 16. Drug Saf. 2021. PMID: 33725335 Free PMC article. Review.
Value of liver biopsy in the diagnosis of drug-induced liver injury.
Ahmad J, Barnhart HX, Bonacini M, Ghabril M, Hayashi PH, Odin JA, Rockey DC, Rossi S, Serrano J, Tillmann HL, Kleiner DE; Drug-Induced Liver Injury Network. Ahmad J, et al. J Hepatol. 2022 May;76(5):1070-1078. doi: 10.1016/j.jhep.2021.12.043. Epub 2022 Jan 21. J Hepatol. 2022. PMID: 35074471 Free PMC article.
617 results